Wuhan Vanz Pharm Inc.

 

Wuhan Vanz Pharm Inc., Your reliable supplier!

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
Home ProductsPharmaceutical Raw Materials

99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication

I'm Online Chat Now
China Wuhan Vanz Pharm Inc. certifications
China Wuhan Vanz Pharm Inc. certifications
I am very happy to cooperate with your company for nearly three years, thank you very attentive service, thank you for the excellent product quality.

—— Stephnie

You always have very fast delivery, very happy to cooperate with you. Thank you.

—— John

Very pleased to become your customer, and very happy for our cooperation, hope to be your long-term parter.

—— Sara

we received the package, very fast, the quality is very good, will continue to buy your products.

—— Luice

I have emailed you a couple times and they get returned as undeliverable. Yes. I am happy with the powders. thank you.

—— Bryan

99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication

99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication
99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication 99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication 99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication

Large Image :  99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication Get Best Price

Product Details:

Place of Origin: CHINA(MAINLAND)
Brand Name: VANZ
Certification: COA
Model Number: Medical grade

Payment & Shipping Terms:

Minimum Order Quantity: 100g
Packaging Details: aluminum
Delivery Time: 3days after paid
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 10kg/month
Detailed Product Description
Apperance: White Or Offwhite Powder Purity: 99%min
MF: C8H14N2O2 Grade: Medicine Powder
MW: 170.21 Impurity: 0.001%
High Light:

Pharma Raw Materials

,

medicine raw material

99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication

 

Levetiracetam is used in combination with other medications to treat certain types of seizures in people with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.

 

Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic seizures.

 

Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown to reduce partial (focal) seizures by 50% or more as an add-on medication.

 

It is also used in veterinary medicine for similar purposes.

Levetiracetam is sometimes used off-label to treat status epilepticus or to prevent seizures associated withsubarachnoid hemorrhages.

 

Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, anxiety disorder, and Alzheimer's disease. However, its most serious adverse effects are behavioral, and its benefit-risk ratio in these conditions is not well understood.

 

Levetiracetam has not been found to be useful for treatment of neuropathic pain, nor for treatment of essential tremors.Levetiracetam has not been found to be useful for treating autism, but is an effective treatment for partial, myoclonic, or tonic-clonic seizures associated with autism spectrum disorder.

Pregnancy

Levetiracetam is a Pregnancy Category C Drug. Studies in female pregnant rats have shown minor fetal skeletal abnormalities when given maximum recommended human doses of levetiracetam orally throughout pregnancy and lactation.

Elderly

Studies were conducted to look for increased adverse effects in the elderly population as compared to younger patients. One such study published in Epilepsy Research showed no significant increase in incidence of adverse symptoms experienced by young or elderly patients with central nervous system (CNS) disorders.

Children

Levetiracetam may be used in children depending on age and type of seizure. Animal studies in juvenile rats and dogs did not demonstrate a potential for age-specific toxicity.

Kidney impairment

Kidney impairment decreases the rate of elimination of levetiracetam from the body. Individuals with reduced kidney function may require dose adjustments. Kidney function can be estimated from the rate of creatinine clearance.[3]

Liver impairment

Dose adjustment of levetiracetam is not necessary in liver impairment.

 

Specification:

 

TEST ITEMS SPECIFICATIONS
Appearance A white or almost white powder
Identification 1) IR:the infrared Absorption of the test
2) RRT:The retention time of sample corresponds to the standard
Water ≤0.5%
Sulphated ash ≤0.1%
Heavy metals ≤20ppm
Isomer(Impurity D) ≤0.50%
Impurity B ≤0.10%
Related substances  
   
ImpurityA ≤0.05%
Levetiracetam acid ≤0.10%
Any other individual impurity ≤0.05%
Total impurities ≤0.40%
   

 

Package details:

 

Packaging Detail

0.5kgs/Al-bag
1.0kgs/Al- bag
2.0kgs/Al- bag
5.0 kgs/Al-bag
25.0 kgs/drum
or upon customers' request.

Storage Store in a well-closed container away from moisture
Shelf Life 2 years if sealed and store away from direct sun light.
Delivery Detail within 3 days after get the payment

 
Payment

 
ALI PLATFOR, T.T WESTERN UNION, MONEY GRAM
 
 
Company 

 99% Purity Pharmaceutical Raw Materials API Levetiracetam Medication 0
 

 

Contact Details
Wuhan Vanz Pharm Inc.

Contact Person: Jerry

Tel: +8615827051195

Send your inquiry directly to us